Beutler BD
University of Southern California, Keck School of Medicine, Los Angeles, CA.
ArticlePsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
ArticleAyahuasca
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
ArticleLSD
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).
ArticlePsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.
ArticleKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine.
ArticleIbogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine.
ArticleKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics.
ArticleMDMA
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
PreprintKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VII. Ketamine
PreprintKetamine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VIII. The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
PreprintAyahuasca
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and Ayahuasca
PreprintPsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part I. Historical Perspective and Overview
PreprintIbogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part V. Ibogaine
PreprintLSD
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part II. Lysergic acid diethylamide (LSD)
PreprintPsilocybin
Psychedelic Therapy: A Primer for Primary Care Clinicians – Part IV. Psilocybin
PreprintMDMA